UK Companies House feature
AMICUS THERAPEUTICS UK OPERATIONS LIMITED
Profile
- Company number
- 12148755
- Status
- Active
- Incorporation
- 2019-08-09
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 86900
- Hubs
- UK Healthcare
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Company is dependent upon its ultimate parent company, Amicus Therapeutics Inc., for both product supply and access to cash resources. In view of this, the directors have received written confirmation from Amicus Therapeutics Inc. that they will make funds available to the Company to enable it to meet its liabilities as they fall due for a period of at least 12 months from the date of approval of these financial statements.”
Significant events
- “In August 2023, the Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom (U.K.) has granted marketing authorizations for Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) for adults living with late-onset Pompe disease. Pombiliti + Opfolda was launched in September 2023.”
- “In October 2023, Amicus Therapeutics Inc. entered into a loan agreement with Blackstone for $400m in order to repay existing group debt and provide adequate working capital for the future. Amicus Therapeutics Ltd. provided a first lien security interest over cash held in its bank account and its trade debtor balances.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 4 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CLARK, Laura Ruth | Director | 2024-09-27 | Oct 1982 | British |
| GALVIN, Charlotte Ann | Director | 2019-08-09 | Mar 1978 | British |
| GREEN, Steven John | Director | 2020-06-01 | Apr 1977 | British |
Show 4 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| COLLINS, Simon Timothy Martin | Director | 2019-08-09 | 2024-07-26 |
| LEWIS, David Malcolm | Director | 2024-02-12 | 2024-07-26 |
| MOCHAN, Lori Elizabeth | Director | 2019-08-09 | 2020-02-21 |
| REICHMAN, Nicole Ruth | Director | 2019-08-09 | 2021-04-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Amicus Therapeutics Uk Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-08-09 | Active |
Filing timeline
Last 20 of 25 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-08-11 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-04-07 | AA | accounts | accounts with accounts type full |
| 2024-10-01 | AP01 | officers | appoint person director company with name date |
| 2024-09-05 | AA | accounts | accounts with accounts type full |
| 2024-08-13 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-08-01 | TM01 | officers | termination director company with name termination date |
| 2024-07-26 | TM01 | officers | termination director company with name termination date |
| 2024-02-13 | AP01 | officers | appoint person director company with name date |
| 2023-10-13 | AA | accounts | accounts with accounts type full |
| 2023-10-12 | MR04 | mortgage | mortgage satisfy charge full |
| 2023-10-09 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2023-08-18 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-09-29 | AA | accounts | accounts with accounts type full |
| 2022-08-10 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-08-23 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-06-28 | AA | accounts | accounts with accounts type full |
| 2021-04-06 | TM01 | officers | termination director company with name termination date |
| 2020-08-14 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2020-08-11 | MA | incorporation | memorandum articles |
| 2020-08-11 | RESOLUTIONS | resolution | resolution |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory